
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Sponsored
2026-07-16BGL6-KBlue Gold Limited Shareholder Meeting for Reverse Stock Split and Bylaw AmendmentsHIGH
Blue Gold Limited is holding an extraordinary general meeting on July 24, 2026, to vote on two key proposals. The first is an ordinary resolution to authorize a reverse stock split, consolidating shares at a ratio between 1:2 and 1:200. This measure is intended to address the company's non-compliance with Nasdaq's mini...
GoldShareholder Related
Sponsored
2026-07-16CYBN6-KHelus Pharma Closes US$50 Million Underwritten Offering to Fund Phase 3 MDD ProgramHIGH
On June 25, 2026, Helus Pharma (the commercial operating name of Cybin Inc.) closed an underwritten public offering of 10,309,280 common shares at a price of US$4.85 per share. The offering generated approximately US$50 million in aggregate gross proceeds. Cantor Fitzgerald & Co. and Barclays Capital Inc. served as joi...
BiotechnologyEquity Offering
Sponsored